Moreover, XCR1+ cDC1s, efficient at cross-presenting antigens to CD8+ T cells, were reported to increase hepatic steatosis and contribute to liver pathology, which was associated with inflammatory T cell reprogramming in the liver-draining lymph nodes (8). Here, CD8A is linked to fatty liver disease.